A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391). (academic.oup.com)

Authors: Koethe JR … Gulick RM Journal: Clinical Infectious Diseases Published: 2026-03-18 DOI: https://doi.org/10.1093/cid/ciag196